I agree with details provided by @kpcross and @David . The usual difference on selection of particular TD50 value by FDA/EMA/ICH is due to consideration of how human relevant and reliable observed effects and study data are overall by different authorities. Also, thanks to lhasa for taking lead to maintain crucial CPDB information after NIH back step.
1 Like